Bonyeza Hapa kwa Toleo la Kihispania la Ukurasa Huu / Versión en español de esta página
Bonyeza Hapa kwa Toleo la Kiebrania la Ukurasa Huu
Bonyeza Hapa kwa Toleo la Kirusi la Ukurasa Huu
Bonyeza Hapa kwa Toleo la Kiukreni la Ukurasa Huu
Bonyeza Hapa kwa Toleo la Kikorea la Ukurasa Huu
Research Trials
December, 2024 – Cognition Therapeutics Announces Positive Results in Phase 2 Study of CT1812 in Dementia with Lewy Bodies. They released their data from the SHIMMER study in an investor call. You can listen to the recorded call here:
https://ir.cogrx.com/events/investor-webinar-analysis-of-topline-phase-2-dlb-results/